3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
927
Neoplasms
609
Breast Neoplasms
606
Colorectal Neoplasms
457
Neoplasm Metastasis
395
Ovarian Neoplasms
327
Prostatic Neoplasms
314
Melanoma
311
Lung Neoplasms
295
Multiple Myeloma
290
Recurrence
278
Squamous Cell Carcinoma of Head and Neck
246
Stomach Neoplasms
229
Pancreatic Neoplasms
227
Leukemia, Myeloid, Acute
221
Triple Negative Breast Neoplasms
190
Endometrial Neoplasms
190
Carcinoma, Renal Cell
181
Lymphoma, Non-Hodgkin
179
Carcinoma, Hepatocellular
179
Small Cell Lung Carcinoma
165
Leukemia, Lymphocytic, Chronic, B-Cell
156
Advanced Solid Tumors
155
Lymphoma, Follicular
149
Urinary Bladder Neoplasms
139
Lymphoma, Large B-Cell, Diffuse
138
Lymphoma
137
Advanced Solid Tumor
137
Uterine Cervical Neoplasms
134
Head and Neck Neoplasms
134
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Suicidal Ideation
×
1 year
×
Clear all
NCT03284879
2025-09-08
Post-Marketing Surveillance Study of OTEZLA
Amgen
Completed
1,086 enrolled